Introduction
A timely diagnosis and categorization of myocardial pathology has therapeutic and prognostic implications with crucial importance to the understanding of the underlying cardiomyopathy [Bennett et al. 2013] . The endomyocardial biopsy (EMB) guided by fluoroscopic and echocardiographic guidance carries a relatively low complication risk profile [Cooper et al. 2007 ], but its diagnostic yield in patients with a nonuniform, patchy myocardial disease distribution (e.g. sarcoidosis, focal myocarditis) remains modest [Cooper et al. 2007; From et al. 2011; Bennett et al. 2013] . Identification of fractionated and low-voltage electrograms by three-dimensional endocardial electroanatomical mapping (3DEAM) can localize the areas of myocardium affected by pathology, and pilot data support the notion that EMB based on 3DEAM can improve the diagnostic yield [Sasaki et al. 2013; Liang et al. 2014] . Visualization of the bioptome in realtime on 3DEAM as well as the recording of both unipolar and bipolar electrograms from the bioptome tip would help in increasing the effectiveness and safe ascertainment of analyzable tissue.
Procedure

Preparation
After providing informed consent, the procedure was performed under conscious sedation in the electrophysiological laboratory equipped with fluoroscopy, transthoracic echocardiography, and the 3DEAM system (EnSite NavX, St Jude Medical, Minnetonka, MN, USA). Vascular A bioptome, configured to record an electrogram from the tip, was then visualized on the three-dimensional electroanatomic mapping (3DEAM) system, and directed to these areas. The biopsy was assisted by the use of a steerable introducer sheath, and by recording unipolar and extended bipolar signals from the bioptome tip. A prominent change in the signal was detected by the electrode at the bioptome tip when the jaws closed on the endomyocardial tissue. Patient tolerated the procedure without complications, and the biopsied samples were appropriate for pathological analysis. Conclusions: Using existing technology, the 3DEAM, which integrates unipolar and bipolar signal from the bioptome tip, is feasible, and can be safely added to a standard echocardiographically guided endomyocardial biopsy. Future studies should investigate whether such a technique could increase the safety and diagnostic yield of endomyocardial biopsies in patients with suspected cardiomyopathies. Original Research access with two short sheaths in the right femoral vein (8 Fr, 9 Fr) was obtained, and a radial arterial line was placed for hemodynamic monitoring. A steerable flexible long sheath (Agilis NxT 9.5 Fr, lumen length 91 cm, St Jude Medical) was exchanged for the 9 Fr short sheath and advanced to the heart over a wire under fluoroscopic guidance. A long 8 Fr SR0 sheath was exchanged for the 8 Fr short sheath and advanced to the right atrium in a similar fashion. A mapping catheter with standard bidirectional curves (Blazer EPT 5 mm tip, 7 Fr × 110 cm, Boston Scientific, San Jose, CA, USA) was connected to the 3DEAM and threaded via the SR0 sheath to the right ventricle (RV). Biopsy forceps (Bipal 7, 7 Fr × 104 cm, Cordis Corporation, Miami Lakes, FL, USA) were connected to the 3DEAM (Figure 1) 
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Mapping and biopsy
The RV was mapped by the EPT catheter and the 3DEAM model identified locations with abnormally fractionated near-field signals and low-voltage signals (red and orange colored areas in Figure 2a ). The area situated at the midventricular septum was deemed amenable for a safe biopsy retrieval (black asterisk in Figure 2a) , and the EPT catheter tip was positioned to its close proximity. The bioptome was then advanced by the steerable sheath so that its tip was aimed at the area of interest using guidance by fluoroscopy and 3DEAM (Figure 2a-2d ) . Unipolar (bioptome tip to Wilson's central terminal) and an extended bipole (bioptome tip to the nearby EPT catheter tip) tracings from the bioptome confirmed fractionated electrograms (Figure 2d) , and visualization of the bioptome against the interventricular septum by transthoracic echocardiogram was performed for additional safety. When the bioptome jaws were closed on the endomyocardial tissue, a prominent change in the detected signal was recorded (Figure 3) . A total of five biopsy samples were obtained using this technique and were subsequently judged as sufficient for analysis by the pathologist: they revealed a fibrotic endocardium with mildly hypertrophied myocytes without inflammation or granuloma.
Discussion
Using existing technology, this demonstration of a novel technique supports the plausibility of integrating a bioptome with 3DEAM during a standard echocardiographically guided biopsy. The novel findings from this report are: (a) the bioptome tip can be connected with the 3DEAM system without compromising the functionality of the forceps; (b) a flexible long sheath helps in improving the maneuverability of the bioptome in the RV; (c) simultaneous visualization of the bioptome and the reference catheter is possible in real time during the biopsy; (d) unipolar and bipolar recordings help to confirm the appropriate location just before biopsy ascertainment; (e) an electrogram recorded by the bioptome changes acutely when the jaws close tightly on the endomyocardial tissue, which may help identify a 'good grab' (sufficient tissue enclosed in the forceps amenable for retrieval). Future studies should investigate whether the technique could provide increased yield and safety of endomyocardial biopsies in patients with suspected cardiomyopathies.
